Bipolar mood disorders;Bipolaire stemmingsstoornissen

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 41, 2007, Pages 2256-2260

  Kupka, R W ^a   Regeer, E J ^a  

^a Altrecht   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

BIPOLAR DISORDER; DISEASE SEVERITY; FUNCTIONAL DISEASE; INCIDENCE; NEUROBIOLOGY; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW; SYMPTOM; HOSPITALIZATION; HUMAN; PREVALENCE; PROGNOSIS; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; PREVALENCE; PROGNOSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38449114164     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision (DSM-IV-TR). Washington: American Psychiatric Press; 2000.
2. Koster van Groos GAS. Beknopte handleiding bij de diagnostische criteria van de DSM-IV-TR. Lisse: Swets & Zeitlinger; 2001.
3. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996;16(2 Suppl 1):4S-14S.
4. Chun BJ, Dunner DL. A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. Bipolar Disord. 2004;6:32-42.
5. Have M ten, Vollebergh W, Bijl R, Nolen WA. Bipolar disorder in the general population in the Netherlands (prevalence, consequences and care utilisation): results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord. 2002;68:203-13.
6. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
7. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-27.
8. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53-9.
9. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord. 2003;5:456-63.
10. Horwitz AV, Wakefield JC. The loss of sadness. How psychiatry transformed normal sorrow into depressive disorder. Oxford: Oxford University Press; 2007.
11. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:629-40.
12. Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. 2005;18:233-9.
13. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530-7.
14. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60:497-502.
15. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry. 2006;60:93-105.
16. Hajek T, Carrey N, Alda M. Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord. 2005;7:393-403.
17. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006;93:105-15.
18. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord. 2006;8:103-16.
19. Berg B van den, Knoppert-van der Klein EAM, Zaane J van. Psychotherapeutische behandelingsmogelijkheden voor bipolaire stoornissen. Tijdschrift voor Psychiatrie. 2006;48:905-13.
20. Nolen WA. Farmacotherapie voor de bipolaire stoornis. Ned Tijdschr Geneeskd. 1999;143:1299-305.
21. Nederlandse Vereniging voor Psychiatrie. Richtlijn bipolaire stoornissen. Amsterdam: Boom; 2001.
22. Bauer MS, Mitchner L. What is a 'mood stabilizer'? An evidence-based response. Am J Psychiatry. 2004;161:3-18.
23. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders [Cochrane review]. Cochrane Database Syst Rev. 2001;(2):CD003013.
24. Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord. 2007;9:394-412.
25. Visser HM, Mast RC van der. Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review. World J Biol Psychiatry. 2005;6:231-41.
26. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161:1537-47.
27. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007;64:442-55.
28. Gao K, Calabrese JR. Newer treatment studies for bipolar depression. Bipolar Disord. 2005;7 Suppl 5:13-23.
29. Hellewell JS. A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders. J Psychopharmacol. 2006;20(2 Suppl):39-45.
30. Loos MLM van der, Kölling P, Knoppert-van der Klein EAM, Nolen WA. Lamotrigine bij de behandeling van bipolaire stoornissen. Tijdschrift voor Psychiatrie. 2007;49:94-104.
31. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. 2007;9:531-5.